NGS Sample Preparation Market worth $4.0 billion by 2028
In order to determine the current size of the NGS sample preparation market, this study engaged in four main actions. A thorough investigation was conducted using secondary research methods to gather data about the market, its parent market, and its peer markets. The following stage involved conducting primary research to confirm these conclusions, hypotheses, and sizing with industry experts throughout the value chain. A combination of top-down and bottom-up methods was used to assess the overall market size. Subsequently, methods for data triangulation and market breakdown were employed to estimate the market size of various segments.
The entire size of the NGS sample preparation market was estimated and validated using both top-down and bottom-up methods. The size of different market subsegments was also widely estimated using these techniques. The following is a list of the research methods utilized to determine the market size:
# The key players in the industry and market have been identified through extensive secondary research
# The revenues generated from the NGS sample preparation business of leading players have been determined through primary and secondary research
# All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=69735098
Major Growth Driving Factors:
The use of NGS as a PCR substitute, the development of NGS platforms, the decreasing cost of sequencing, the efficiency of genotyping and preparation methods, and others are some of the key drivers propelling the growth of this industry. The development of the market, however, may be hampered by the existence of substitute technologies that lack the specific knowledge and sequencing capacities of individual laboratories.
Revenue Growth Projections:
Revenue from the global NGS sample preparation market was projected to be $1.9 billion in 2022 and is expected to rise at a compound annual growth rate (CAGR) of 13.4% from 2022 to 2028, when it is expected to reach $4.0 billion.
Following the completion of the market size estimation process, the entire market was divided into multiple parts. Data triangulation and market breakdown processes were used where appropriate to finish the entire market engineering process and provide precise statistics for every category. Through an analysis of numerous variables and patterns from the supply and demand sides, the data was triangulated.
Driver: Increased effectiveness of preparation and genotyping procedures
Due to its high resolution available for genotyping, human whole genome sequencing has been developing tremendously in recent years and has set a new standard for itself in the bacterial infection outbreak. Because NGS sample preparation is used for genotyping, it has proven to be the most important technology for investigating bacterial outbreaks. NGS sample preparation is primarily carried out using Illumina machines, while other major companies such as ThermoFisher and PerkinElmer can also be employed. Because it requires less hands-on time and can operate with small amounts of DNA, enzymatic fragmentation library preparation is superior to other techniques.
Restraint: Existence of substitute technologies
Additional methods for diagnosing different diseases include the use of Sanger, antigen testing, polymerase chain reaction (PCR), and serological testing. Sanger sequencing has dominated genomics research for the last 20 years and produced several noteworthy advances in the field. By looking for antibodies in the blood, serological tests are performed to identify the viruses present in the body. Numerous antibodies produced by the immune system can also be found by serological testing.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=69735098
Opportunity: Growing alliances and cooperation amongst important actors
Many major actors, including hospitals, clinics, academic institutions, research labs, and other pharmaceutical and biotechnology corporations, are working together. Examples of these partners include Illumina, Thermo Fisher Scientific, and PerkinElmer. New products, research projects, and technologies are being introduced to the market as a result of these tactics. The growing use of NGS sample preparation is anticipated to make these projects lucrative growth possibilities for market participants.
The market for NGS sample preparation is highly consolidated, with key players strategizing to capture the market. Prominent players in the NGS sample preparation market are Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), PerkinElmer Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Agilent Technologies, Inc. (US), Danaher (US), Becton, Dickinson and Company (US), Merck KGAA (Germany), QIAGEN (Germany), Bio-Rad Laboratories, Inc. (US), Promega Corporation (US), Eurofins Scientific (Luxembourg), BGI (China), 10x Genomics (US), Sysmex Corporation (US), Psomagen (US), Zymo Research Corporation (US), Takara Bio Inc. (Japan), Novogene Co., Ltd. (China), New England Biolabs (US), Tecan Trading AG (US), Oxford Nanopore Technologies PLC (UK), PacBio (US), Medgenome (US), and Swift Biosciences Inc. (US).
Different Growth Strategies Adopted by Them:
Most companies in the market focus on organic and inorganic growth strategies, such as service launches, expansions, acquisitions, partnerships, agreements, and collaborations, to increase their service offerings, cater to the unmet needs of customers, increase their profitability, and expand their presence in the global market.
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
